Seagull BioSolutions, a startup working on new biological technologies, is being funded by the Department of Science and Technology (DST), to undertake the development of Active Virosome (AV)-Vaccine and Immunodiagnostic kits for COVID-19 emergency.
Active Virosome Technology (AVT) developed by...
